Peripheral Vascular Devices Market 2023–2031 Outlook: Forecast to US$ 18.5 Billion and Key Growth Drivers
Peripheral vascular devices are medical devices used to diagnose, treat, and manage diseases affecting blood vessels outside the heart and brain, such as those in the legs, arms, and abdomen. These devices are commonly used to treat conditions like peripheral artery disease (PAD) by improving blood flow and reducing vessel blockages. They include products such as catheters, guidewires, balloons, stents, and atherectomy devices. Peripheral vascular devices help support minimally invasive procedures, reduce recovery time, and improve patient outcomes, making them an essential part of modern vascular care.
The peripheral vascular devices market is positioned for steady growth between 2023 and 2031, supported by rising disease prevalence, technological innovation, and expanding healthcare access worldwide. The market size is projected to increase from US$ 12.5 billion in 2023 to US$ 18.5 billion by 2031, registering a CAGR of 5.7 percent over the forecast period. Peripheral vascular devices are essential in diagnosing and treating conditions such as peripheral artery disease, deep vein thrombosis, and chronic venous insufficiency, which are becoming increasingly common due to demographic and lifestyle trends.
Market Overview and Disease Burden
Peripheral vascular disease represents a major and growing public health challenge. Aging populations, combined with higher incidence of diabetes, obesity, smoking, and sedentary lifestyles, are significantly increasing the number of patients requiring vascular intervention. In the United States alone, millions of adults are affected by peripheral vascular conditions, particularly among individuals aged 60 years and older. Similar trends are being observed across Europe and parts of Asia Pacific, reinforcing long term demand for peripheral vascular devices.
Healthcare systems are increasingly favoring minimally invasive treatments for vascular disorders, which further supports adoption of advanced catheters, guidewires, and stent technologies. These procedures offer reduced recovery time, lower complication rates, and shorter hospital stays compared to traditional surgical approaches.
Key Growth Drivers
One of the strongest growth drivers is the rising geriatric population. Vascular elasticity decreases with age, making older adults more susceptible to arterial blockages and venous disorders. As populations in regions such as Europe and North America continue to age, demand for interventional vascular procedures is expected to remain strong.
Lifestyle related risk factors also play a significant role. Smoking, excessive alcohol consumption, and obesity contribute directly to vascular inflammation and plaque buildup. This has increased the clinical need for angioplasty balloons, atherectomy devices, and drug eluting stents designed to reduce restenosis rates.
Technological advancements are another critical factor. Innovations such as drug coated balloons, bioresorbable vascular scaffolds, and improved atherectomy systems are enhancing clinical outcomes. These technologies allow more precise lesion treatment and improved long term vessel patency, encouraging physicians to adopt newer device generations.
Product Segmentation Insights
By product category, peripheral vascular stents accounted for the largest market share in 2023 due to their widespread use in treating peripheral artery disease. Drug eluting stents and covered stents are increasingly preferred as they help reduce repeat interventions.
Peripheral transluminal angioplasty balloon catheters are expected to witness the fastest growth rate through 2031. Their versatility, lower cost compared to stents, and compatibility with drug coatings make them attractive for first line treatment in many cases. Atherectomy devices and chronic total occlusion devices are also gaining adoption for complex and heavily calcified lesions.
End User Trends
Hospitals and clinics remain the dominant end users, accounting for the largest share of procedures globally. These settings are equipped with advanced imaging systems and skilled interventional specialists, making them the primary sites for complex vascular interventions. Ambulatory care centers are expected to grow steadily as minimally invasive procedures shift toward outpatient settings, supported by favorable reimbursement policies in developed markets.
Get a Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00002776
Regional Analysis
North America holds a leading position in the peripheral vascular devices market, driven by high disease awareness, advanced healthcare infrastructure, and early adoption of innovative devices. Europe also represents a significant share, supported by government backed healthcare systems and increasing use of minimally invasive vascular procedures.
Asia Pacific is anticipated to witness the fastest growth during the forecast period. Rising healthcare investments, expanding access to interventional cardiology services, and a growing aging population in countries such as China and India are contributing to this trend.
Key Market Players
Abbott
Strong portfolio in peripheral stents and balloon technologies
Medtronic
Focus on minimally invasive vascular solutions
Boston Scientific Corporation
Leader in atherectomy and drug coated balloon devices
Terumo Corporation
Known for high precision guidewires and catheters
B. Braun Melsungen AG
Broad vascular access and surgical graft portfolio
Future Outlook
Looking ahead, the peripheral vascular devices market is expected to benefit from continued innovation and expanding patient populations. Advancements in drug delivery technologies, bioresorbable materials, and image guided interventions will further improve treatment outcomes. As healthcare systems increasingly emphasize early diagnosis and minimally invasive care, peripheral vascular devices will remain central to managing vascular disease globally through 2031.
Related Reports
Cell Therapy CDMO Market Size, Share and Forecast by 2031
Oscillometry Market Size, Share & Trends Analysis 2031
dPCR Market Size, Share, Trends & Growth 2031
Cell and Gene Therapy Market Growth & Future Trends 2031
Joint Replacement Devices Market Size & Growth Drivers 2031
Peripheral Vascular Devices Market Growth and Analysis by 2031

Comments
Post a Comment